Calculation
of Registration Fee
Title of Each Class of
Securities Offered
|
|
Maximum Aggregate
Offering Price
|
|
Amount of
Registration Fee
(1)
|
|
|
|
|
|
Debt Securities
|
|
$576,000
|
|
$78.57
|
|
|
|
|
|
Debt Securities
|
|
$1,395,000
|
|
$190.28
|
(1)
Calculated in accordance with Rule 457(r) of
the Securities Act of 1933, as amended.
Filed Pursuant
to Rule 424(b)(2)
Registration
No. 333-180289
PRICING
SUPPLEMENT
Dated February
22, 2013
(To Prospectus
dated March 22, 2012,
Prospectus
Supplement dated March 22, 2012 and
Stock-Linked
Underlying Supplement dated March 22, 2012)
HSBC USA Inc.
7 Year Income Plus Notes
|
}
|
This pricing supplement relates to two separate offerings:
|
|
–
|
$576,000 7 Year Income Plus Notes with a 1.00% Minimum Annual Coupon (Note A)
|
|
–
|
$1,395,000 7 Year Income Plus Notes with a 0.50% Minimum Annual Coupon (Note B)
|
|
}
|
Linked to a basket of 5 Reference Stocks
|
|
}
|
Repayment of principal at maturity
|
|
}
|
Annual coupons based on the performance of every Reference Stock, subject to the applicable Minimum Coupon Rate and the applicable
Performance-Based Coupon Rate
|
|
}
|
All payments on the Notes are subject to the credit risk of HSBC USA Inc.
|
The 7 Year Income Plus Notes
(each a “Note” and collectively the “Notes”) offered hereunder will not be listed on any U.S. securities
exchange or automated quotation system.
Neither the U.S. Securities and
Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of the Notes or passed
upon the accuracy or the adequacy of this document, the accompanying prospectus, prospectus supplement or Stock-Linked Underlying
Supplement. Any representation to the contrary is a criminal offense.
We have appointed HSBC Securities
(USA) Inc., an affiliate of ours, as the agent for the sale of the Notes. HSBC Securities (USA) Inc. will purchase the Notes from
us for distribution to other registered broker-dealers or will offer the Notes directly to investors. HSBC Securities (USA) Inc.
or another of its affiliates or agents may use this pricing supplement in market-making transactions in any Notes after their initial
sale. Unless we or our agent informs you otherwise in the confirmation of sale, this pricing supplement is being used in a market-making
transaction. See “Supplemental Plan of Distribution (Conflicts of Interest)” on page PS-14 of this pricing supplement.
Investment in the Notes involves
certain risks. You should refer to “Risk Factors” beginning on page PS-5 of this document, beginning on page S-3 of
the accompanying prospectus supplement and beginning on page S-1 of the accompanying Stock-Linked Underlying Supplement.
|
Price to Public
|
Underwriting Discount
1
|
Proceeds to Issuer
|
Per security / Total for Notes with a 1.00% Minimum Annual Coupon
|
$1,000/$576,000
|
$45/$25,920
|
$955/$550,080
|
Per security / Total for Notes with a 0.50% Minimum Annual Coupon
|
$1,000/$1,395,000
|
$45/$62,775
|
$955/$1,332,225
|
|
|
|
|
1
HSBC USA Inc. or one of our
affiliates may pay varying underwriting discounts of up to 4.25% and referral fees of up to 1.75% per $1,000 Principal Amount
of Notes in connection with the distribution of the Notes to other registered broker-dealers. In no case will the sum of underwriting
discounts and referral fees exceed 4.75% per $1,000 Principal Amount. See “Supplemental Plan of Distribution (Conflicts
of Interest)” on page PS-14 of this pricing supplement.
The
Notes:
Not FDIC Insured
|
Are Not Bank Guaranteed
|
May Lose Value
|
HSBC USA
Inc.
7 Year Income
Plus Notes
Linked to a basket of 5 Reference Stocks
|
|
This pricing supplement
relates to two separate offerings of Notes linked to a basket of five common stocks (each a “Reference Stock” and the
basket the “Reference Asset”). Each offering will have the terms described in this pricing supplement and the accompanying
Stock-Linked Underlying Supplement, prospectus supplement and prospectus. If the terms of the Notes offered hereby are inconsistent
with those described in the accompanying Stock-Linked Underlying Supplement, prospectus supplement or prospectus the terms described
in this pricing supplement shall control.
Each of the two separate
offerings of Notes has a different Minimum Coupon Rate and Performance-Based Coupon Rate. The purchaser of any Note will acquire
a senior unsecured debt security of HSBC USA Inc. with annual coupons linked to the performance of the Reference Stocks as described
below. The following key terms relate to the offerings of Notes:
Issuer:
|
HSBC USA Inc.
|
|
|
Principal Amount:
|
$1,000 per Note
|
|
Investor preference
|
Potential Annual COUPON
|
CUSIP/ ISIN
|
|
Minimum Coupon Rate
1
|
Performance-Based Coupon Rate
2
|
Minimum Coupon Rate or Combined Return
3
|
|
A
|
1.00%
|
4.50%
2
|
1.00% or 5.50%
|
40432XB26/US40432XB262
|
B
|
0.50%
|
8.00%
2
|
0.50% or 8.50%
|
40432XB34/US40432XB346
|
1
These
preferences denote the comparative payoff characteristics of each Note compared with the other Note offered herein and do not reflect
a comparison with any other financial product. Investor Preferences are not drawn to scale.
2
Payment
of any Performance-Based Coupon Rate is subject to the Final Price of each Reference Stock on the applicable Coupon Valuation Date
being greater than or equal to its Initial Price.
3
The Minimum Coupon Rate and Performance-Based
Coupon Rate are shown together.
Reference Stocks:
|
The common stocks of the Reference Stock Issuers
:
|
Reference Stock Issuers
|
Ticker Symbol
|
Relevant Exchange
|
Industry
|
Initial Price
1
|
Market Capitalization
2
(in billions)
|
Bristol-Myers Squibb Company
|
BMY
|
NYSE
|
Large Pharmaceuticals
|
$36.90
|
$60.42
|
ConocoPhillips
|
COP
|
NYSE
|
Integrated Oils
|
$58.20
|
$71.06
|
Intel Corporation
|
INTC
|
NASDAQ
|
Semiconductor Devices
|
$20.42
|
$100.10
|
AT&T Inc.
|
T
|
NYSE
|
Telecom Carriers
|
$35.68
|
$195.94
|
Walgreen Co.
|
WAG
|
NYSE
|
Pharmacies & Drug Stores
|
$41.81
|
$39.51
|
1
For each Reference Stock, the Official Closing Price of such Reference Stock on the Pricing Date.
|
2
Market capitalization (in billions) as of 2/22/2013.
Source: Bloomberg L.P.
Payment at Maturity:
|
For each Note, the Principal Amount plus any Coupon due on the Maturity Date.
|
|
|
Coupon:
|
With respect to each Coupon Payment Date, for each $1,000 Principal
Amount of Notes, the Coupon will be calculated as follows:
On the applicable Coupon Valuation Date,
if the Reference Stock Return for
every
Reference
Stock is greater than or equal to zero,
you will receive:
$1,000 x (Performance-Based Coupon Rate + Minimum Coupon Rate)
On the applicable
Coupon Valuation Date, if the Reference Stock Return for
any
Reference
Stock is less than zero
, you will receive:
$1,000 x Minimum Coupon Rate
|
|
|
Reference Stock Return:
|
For each Reference Stock, on any Coupon Valuation Date:
Final Price
— Initial Price
Initial Price
|
|
|
Minimum Coupon Rate:
|
The relevant per annum Minimum Coupon Rate, as indicated above
|
|
|
Performance-Based
Coupon Rate:
|
The relevant per annum Performance-Based Coupon Rate, as indicated above
|
Coupon Valuation Dates
|
Coupon Valuation Date*
|
Coupon Payment Date
|
|
and Coupon Payment
|
February 24, 2014
|
February 27, 2014
|
|
Dates
:
|
February 24, 2015
|
February 27, 2015
|
|
|
February 24, 2016
|
February 29, 2016
|
|
|
February 22, 2017
|
February 27, 2017
|
|
|
February 22, 2018
|
February 27, 2018
|
|
|
February 22, 2019
|
February 27, 2019
|
|
|
February 24, 2020
|
February 27, 2020 (the Maturity Date)
|
|
|
*
Subject to the adjustment as described under “Additional Note Terms — Valuation Dates” in the accompanying Stock-Linked Underlying Supplement.
|
Initial Price:
|
The Official Closing Price (as defined below) of the respective Reference Stock as determined by the calculation agent on the Pricing Date, as indicated above.
|
|
|
Final Price:
|
The Official Closing Price of the respective Reference Stock on the relevant Coupon Valuation Date, adjusted as described under “Additional Note Terms — Antidilution and Reorganization Adjustments” in the accompanying Stock-Linked Underlying Supplement.
|
|
|
Official Closing Price:
|
With respect to each Reference Stock, the Official Closing Price will be the relevant official price of one share of such Reference Stock on its Relevant Exchange as of the close of the regular trading session of such exchange and as reported in the official price determination mechanism for such exchange, as further described under “Additional Note Terms — Official Closing Price” in the accompanying Stock-Linked Underlying Supplement.
|
|
|
Trade Date:
|
February 22, 2013
|
|
|
Pricing Date:
|
February 22, 2013
|
|
|
Original Issue Date:
|
February 27, 2013
|
|
|
Maturity Date:
|
February 27, 2020. The Maturity Date is subject to adjustment as described under “Coupon Payment Dates, Call Payment Dates and Maturity Date” in the accompanying Stock-Linked Underlying Supplement.
|
|
|
Form of Notes:
|
Book-Entry
|
|
|
Listing:
|
The Notes will not be listed on any U.S. securities exchange or quotation system.
|
General
This pricing supplement relates to two
separate offerings of Notes, each linked to the Reference Stocks identified on page PS-2. The purchaser of any Note will acquire
a senior unsecured debt security of HSBC USA Inc. linked to five Reference Stocks. Although each of the two offerings of Notes
relates to the Reference Stocks identified on page PS-2, you should not construe that fact as a recommendation as to the merits
of acquiring an investment linked to the Reference Stocks or as to the suitability of an investment in the Notes.
You should read this document together
with the prospectus dated March 22, 2012, the prospectus supplement dated March 22, 2012 and the Stock-Linked Underlying Supplement
dated March 22, 2012. If the terms of the Notes offered hereby are inconsistent with those described in the accompanying prospectus
supplement, prospectus or Stock-Linked Underlying Supplement, the terms described in this pricing supplement shall control. You
should carefully consider, among other things, the matters set forth in “Risk Factors” beginning on page PS-5 of this
pricing supplement, beginning on page S-3 of the prospectus supplement and beginning on page S-1 of the Stock-Linked Underlying
Supplement, as the Notes involve risks not associated with conventional debt securities. We urge you to consult your investment,
legal, tax, accounting and other advisors before you invest in the Notes. As used herein, references to the “Issuer”,
“HSBC”, “we”, “us” and “our” are to HSBC USA Inc.
HSBC has filed a registration statement
(including a prospectus, prospectus supplement and Stock-Linked Underlying Supplement) with the SEC for the offering to which this
pricing supplement relates. Before you invest, you should read the prospectus, prospectus supplement and Stock-Linked Underlying
Supplement in that registration statement and other documents HSBC has filed with the SEC for more complete information about HSBC
and this offering. You may get these documents for free by visiting EDGAR on the SEC’s web site at www.sec.gov. Alternatively,
HSBC Securities (USA) Inc. or any dealer participating in this offering will arrange to send you the prospectus, prospectus supplement
and Stock-Linked Underlying Supplement if you request them by calling toll-free 1-866-811-8049.
You may also obtain:
Payment at Maturity
On the Maturity Date, for each Note you
hold, we will pay you your Principal Amount plus any Coupon due on the Maturity Date.
Coupons
On each Coupon Payment Date, we will pay
you the relevant Coupon relating to your Note. The Coupon will vary, will be calculated on the relevant Coupon Valuation Date and
will be equal to the relevant Minimum Coupon Rate or, if applicable, the relevant Performance-Based Coupon Rate plus the Minimum
Coupon Rate. If, on a Coupon Valuation Date, the Reference Stock Return for
every
Reference Stock is equal to or greater
than zero, the Coupon will be the Performance-Based Coupon Rate plus the Minimum Coupon Rate. If, on a Coupon Valuation Date, the
Reference Stock Return for
any
Reference Stock is less than zero, the Coupon will be the Minimum Coupon Rate. The Minimum
Coupon Rate and Performance-Based Coupon Rate will differ for each of the two offerings of Notes offered by this pricing supplement.
The Coupon Payment Dates and the Maturity Date are subject to adjustment, as described under “Additional Note Terms —
Coupon Payment Dates, Call Payment Dates and Maturity Date” in the accompanying Stock-Linked Underlying Supplement. For information
regarding the record dates applicable to the Notes, please see the section entitled “Description of Notes — Interest
and Principal Payments — Recipients of Interest Payments” on page S-11 in the accompanying prospectus supplement.
Calculation
Agent
We or one of our affiliates will act as
calculation agent with respect to the Notes.
Investor Suitability
The Notes may be suitable for you if:
|
|
The Notes may not be suitable for you if:
|
|
|
|
}
You seek an investment that provides a full repayment of principal, subject to the credit risk of HSBC, if held to maturity,
and an annual Coupon, based on the performance of each Reference Stock, that will be equal to the applicable Minimum Coupon Rate
or, if applicable, the applicable Performance-Based Coupon Rate plus the applicable Minimum Coupon Rate.
}
You believe the prices of all of the Reference Stocks will generally increase or remain equal to their Initial Prices over
the term of the Notes.
}
You are willing to accept the risk and return profile of the securities versus a conventional debt security with a comparable
maturity issued by HSBC or another issuer with a similar credit rating.
}
You believe the applicable Coupon on the Coupon Payment Dates will be an amount sufficient to provide you with a satisfactory
return on your investment.
}
You are comfortable receiving only the Principal Amount of your Notes at maturity plus the applicable Coupon that will not
be less than the applicable Minimum Coupon Rate or greater than the applicable Performance-Based Coupon Rate plus the applicable
Minimum Coupon Rate.
}
You are willing to invest in the Notes based on the sum of the applicable Performance-Based Coupon Rate plus the applicable
Minimum Coupon Rate, which will limit your Coupon on any Coupon Payment Date.
}
You are willing to forgo dividends or other distributions paid to holders of the Reference Stocks.
}
You do not seek an investment for which there is an active secondary market.
}
You are willing to hold the Notes to maturity.
}
You are comfortable with the creditworthiness of HSBC, as Issuer of the Notes.
|
|
}
You
seek an investment where the return is based on the actual performance of the Reference Stocks and is not limited to the applicable
Performance-Based Coupon Rate.
}
You
believe the prices of one or more of the Reference Stocks will decrease over the term of the Notes.
}
You
are unwilling to receive only the Principal Amount of your Notes at maturity plus the applicable Coupon that will not be less than
the applicable Minimum Coupon Rate or greater than the applicable Performance-Based Coupon Rate plus the applicable Minimum Coupon
Rate.
}
You
prefer the lower risk, and therefore accept the potentially lower returns, of conventional debt securities with comparable maturities
issued by HSBC or another issuer with a similar credit rating.
}
You
prefer to receive the dividends or other distributions paid on any of the Reference Stocks.
}
You
seek an investment for which there will be an active secondary market.
}
You
are unable or unwilling to hold the Notes to maturity.
}
You are not willing or are unable to assume the credit risk associated with HSBC, as Issuer of the Notes.
|
Risk Factors
We urge you to read the section “Risk
Factors” beginning on page S-3 in the accompanying prospectus supplement and on page S-1 of the accompanying Stock-Linked
Underlying Supplement. Investing in the Notes is not equivalent to investing directly in any of the Reference Stocks. You should
understand the risks of investing in the Notes and should reach an investment decision only after careful consideration, with your
advisors, of the suitability of the Notes in light of your particular financial circumstances and the information set forth in
this pricing supplement and the accompanying Stock-Linked Underlying Supplement, prospectus supplement and prospectus.
In addition to the risks discussed below,
you should review “Risk Factors” in the accompanying prospectus supplement and Stock-Linked Underlying Supplement,
including the explanation of risks relating to the Notes described in the following sections:
|
}
|
“— Risks Relating to All Note Issuances” in the prospectus supplement; and
|
|
}
|
“— General risks related to Reference Stocks” in the Stock-Linked Underlying
Supplement.
|
You will be subject to significant risks
not associated with conventional fixed-rate or floating-rate debt securities.
The amount
of the annual Coupon is uncertain and may be as low as
the Minimum Coupon Rate
.
The amount of the annual Coupon you receive
is not fixed and will depend on the performance of each Reference Stock on the respective Coupon Valuation Dates. If the Reference
Stock Return of
any
Reference Stock is less than zero on a Coupon Valuation Date, you will receive a Coupon equal to the
applicable Minimum Coupon Rate on the applicable Coupon Payment Date. The applicable Minimum Coupon Rate is specified on page PS-2.
You will not directly participate in
any appreciation in the value of Reference Stocks and your Coupon is limited to the applicable Performance-Based Coupon Rate plus
the applicable Minimum Coupon Rate.
You will not directly participate in any
appreciation in the value of the Reference Stocks. Instead, you will receive annual Coupons based upon the applicable formulas
described under the captions “Coupon,” “Minimum Coupon Rate” and “Performance-Based Coupon Rate”
on page PS-2. The Coupons payable to you will be based upon whether the Reference Stocks appreciate or depreciate. Regardless of
the extent to which the prices of the Reference Stocks appreciate, the applicable Coupon will not exceed the applicable Performance-Based
Coupon Rate plus the applicable Minimum Coupon Rate. Therefore, you may earn significantly less by investing in the Notes than
you would have earned by investing directly in the Reference Stocks relevant to your Notes.
The Notes are subject to the credit
risk of HSBC USA Inc.
The Notes are senior unsecured debt obligations
of the Issuer, HSBC, and are not, either directly or indirectly, an obligation of any third party. As further described in the
accompanying prospectus supplement and prospectus, the Notes will rank on par with all of the other unsecured and unsubordinated
debt obligations of HSBC, except such obligations as may be preferred by operation of law. Any payment to be made on the Notes,
including any Coupons or return of principal at maturity, depends on the ability of HSBC to satisfy its obligations as they come
due. As a result, the actual and perceived creditworthiness of HSBC may affect the market value of the Notes and, in the event
HSBC were to default on its obligations, you may not receive the amounts owed to you under the terms of the Notes.
Certain built-in costs are likely to
adversely affect the value of the Notes prior to maturity.
While the payment at maturity described
in this pricing supplement is based on the full Principal Amount of your Notes, the original issue price of the Notes includes
the agent’s commission and the estimated cost of HSBC hedging its obligations under the Notes. As a result, the price, if
any, at which HSBC Securities (USA) Inc. will be willing to purchase Notes from you in secondary market transactions, if at all,
will likely be lower than the original issue price, and any sale prior to the maturity date could result in a substantial loss
to you. The Notes are not designed to be short-term trading instruments. Accordingly, you should be able and willing to hold your
Notes to maturity.
The Notes lack liquidity.
The Notes will not be listed on any securities
exchange. HSBC Securities (USA) Inc. is not required to offer to purchase the Notes in the secondary market, if any exists. Even
if there is a secondary market, it may not provide enough liquidity to allow you to trade or sell the Notes easily. Because other
dealers are not likely to make a secondary market for the Notes, the price at which you may be able to trade your Notes is likely
to depend on the price, if any, at which HSBC Securities (USA) Inc. is willing to buy the Notes.
Potential conflicts.
HSBC and its affiliates play a variety
of roles in connection with the issuance of the Notes, including acting as calculation agent and hedging our obligations under
the Notes. In performing these duties, the economic interests of the calculation agent and other affiliates of ours are potentially
adverse to your interests as an investor in the Notes. We will not have any obligation to consider your interests as a holder of
the Notes in taking any action that might affect the value of your Notes.
The Notes are not insured by any governmental
agency of the United States or any other jurisdiction.
The Notes are not deposit liabilities or
other obligations of a bank and are not insured by the Federal Deposit Insurance Corporation or any other governmental agency or
program of the United States or any other jurisdiction. An investment in the Notes is subject to the credit risk of HSBC, and in
the event that HSBC is unable to pay its obligations as they become due, you may not receive the full payment at maturity of the
Notes.
Tax treatment.
For a discussion of the U.S. federal income
tax consequences of your investment in a Note, please see the discussion under “U.S. Federal Income Tax Considerations”
herein and the discussion under “U.S. Federal Income Tax Considerations” in the accompanying prospectus supplement.
Description
of the Reference Stocks
bristol-myers
squibb company (bmy)
Description of Bristol-Myers Squibb
Company
Bristol-Myers
Squibb Company has stated in its filings with the SEC that it is a global biopharmaceutical company that develops, licenses, manufactures,
markets and sells pharmaceutical and nutritional products. Information filed by BMY with the SEC under the Exchange Act can be
located by reference to its SEC file number: 001-01136 or its CIK Code: 0000014272.
Historical Performance of Bristol-Myers
Squibb Company
The
following table sets forth the quarterly high and low intraday prices, as well as end-of-quarter closing prices on the relevant
exchange, of the Reference Stock for each quarter in the period from October 1, 2007 through February 22, 2013. We obtained the
data in these tables from the Bloomberg Professional
®
service, without independent verification by us. All historical
prices are denominated in US dollars and rounded to the nearest penny.
Historical prices of the Reference Stock should not
be taken as an indication of future performance of the Reference Stock.
Quarter Ending
|
Quarter High
|
Quarter Low
|
Quarter Close
|
|
Quarter Ending
|
Quarter High
|
Quarter Low
|
Quarter Close
|
December 31, 2007
|
$30.23
|
$26.52
|
$26.52
|
|
September 30, 2010
|
$28.00
|
$24.23
|
$27.11
|
March 31, 2008
|
$27.36
|
$20.11
|
$21.30
|
|
December 31, 2010
|
$27.72
|
$25.10
|
$26.48
|
June 30, 2008
|
$23.49
|
$19.43
|
$20.53
|
|
March 31, 2011
|
$27.96
|
$24.97
|
$26.43
|
September 30, 2008
|
$22.92
|
$19.70
|
$20.85
|
|
June 30, 2011
|
$29.48
|
$26.40
|
$28.96
|
December 31, 2008
|
$23.75
|
$16.00
|
$23.25
|
|
September 30, 2011
|
$31.90
|
$25.69
|
$31.38
|
March 31, 2009
|
$23.98
|
$17.24
|
$21.92
|
|
December 30, 2011
|
$35.44
|
$30.10
|
$35.24
|
June 30, 2009
|
$22.13
|
$18.83
|
$20.31
|
|
March 30, 2012
|
$35.44
|
$31.65
|
$33.75
|
September 30, 2009
|
$23.28
|
$19.19
|
$22.52
|
|
June 29, 2012
|
$35.95
|
$32.29
|
$35.95
|
December 31, 2009
|
$26.50
|
$21.67
|
$25.25
|
|
September 28, 2012
|
$36.34
|
$31.37
|
$33.75
|
March 31, 2010
|
$27.07
|
$23.49
|
$26.70
|
|
December 31, 2012
|
$34.55
|
$30.64
|
$32.59
|
June 30, 2010
|
$27.01
|
$22.25
|
$24.94
|
|
February 22, 2013*
|
$37.09
|
$32.17
|
$36.90
|
*
As of the date of this pricing supplement available information for the first calendar quarter of 2013 includes data for the period
from January 2, 2013 through February 22, 2013. Accordingly, the “Quarterly High,” “Quarterly Low” and
“Quarterly Close” data indicated are for this shortened period only and do not reflect complete data for first calendar
quarter of 2013.
The
graph below illustrates the daily performance of BMY’s common stock from February 22, 2008 through February 22, 2013 based
on information from the Bloomberg Professional
®
service. The market price of the Reference Stock on February 22,
2013 was $36.90.
Past performance of the Reference Stock is not indicative of the future performance of the Reference
Stock.
ConocoPhillips
(cop)
Description of ConocoPhillips
ConocoPhillips
has stated in its filings with the SEC that it explores for, produces, transports and markets crude oil, natural gas, natural gas
liquids, liquefied natural gas and butane on a worldwide basis. Information filed by COP with the SEC under the Exchange Act can
be located by reference to its SEC file number: 001-32395 or its CIK Code: 0001163165.
Historical Performance of ConocoPhillips
The
following table sets forth the quarterly high and low intraday prices, as well as end-of-quarter closing prices on the relevant
exchange, of the Reference Stock for each quarter in the period from October 1, 2007 through February 22, 2013. We obtained the
data in these tables from the Bloomberg Professional
®
service, without independent verification by us. All historical
prices are denominated in US dollars and rounded to the nearest penny.
Historical prices of the Reference Stock should not
be taken as an indication of future performance of the Reference Stock.
Quarter Ending
|
Quarter High
|
Quarter Low
|
Quarter Close
|
|
Quarter Ending
|
Quarter High
|
Quarter Low
|
Quarter Close
|
December 31, 2007
|
$68.53
|
$56.55
|
$67.31
|
|
September 30, 2010
|
$44.23
|
$36.64
|
$43.78
|
March 31, 2008
|
$68.39
|
$51.72
|
$58.10
|
|
December 31, 2010
|
$52.28
|
$43.31
|
$51.91
|
June 30, 2008
|
$73.15
|
$57.59
|
$71.96
|
|
March 31, 2011
|
$62.36
|
$50.70
|
$60.88
|
September 30, 2008
|
$72.15
|
$51.31
|
$55.84
|
|
June 30, 2011
|
$62.31
|
$53.43
|
$57.32
|
December 31, 2008
|
$54.93
|
$31.51
|
$39.49
|
|
September 30, 2011
|
$60.99
|
$46.04
|
$48.27
|
March 31, 2009
|
$43.77
|
$26.02
|
$29.85
|
|
December 30, 2011
|
$56.34
|
$44.71
|
$55.55
|
June 30, 2009
|
$37.13
|
$28.60
|
$32.06
|
|
March 30, 2012
|
$59.67
|
$51.84
|
$57.94
|
September 30, 2009
|
$35.91
|
$29.44
|
$34.43
|
|
June 29, 2012
|
$58.94
|
$50.63
|
$55.88
|
December 31, 2009
|
$41.26
|
$34.23
|
$38.93
|
|
September 28, 2012
|
$58.90
|
$52.84
|
$57.18
|
March 31, 2010
|
$41.01
|
$35.56
|
$39.01
|
|
December 31, 2012
|
$59.64
|
$53.96
|
$57.99
|
June 30, 2010
|
$46.14
|
$36.98
|
$37.42
|
|
February 22, 2013*
|
$62.04
|
$56.78
|
$58.20
|
*
As of the date of this pricing supplement available information for the first calendar quarter of 2013 includes data for the period
from January 2, 2013 through February 22, 2013. Accordingly, the “Quarterly High,” “Quarterly Low” and
“Quarterly Close” data indicated are for this shortened period only and do not reflect complete data for first calendar
quarter of 2013.
The
graph below illustrates the daily performance of COP’s common stock from February 22, 2008 through February 22, 2013 based
on information from the Bloomberg Professional
®
service. The market price of the Reference Stock on February 22,
2013 was $58.20.
Past performance of the Reference Stock is not indicative of the future performance of the Reference
Stock.
intel corporation
(intc)
Description of Intel Corporation
Intel
Corporation has stated in its filings with the SEC that it designs, manufactures and sells computer components and related products.
Information filed by INTC with the SEC under the Exchange Act can be located by reference to its SEC file number: 000-06217 or
its CIK Code: 0000050863.
Historical Performance of Intel
Corporation
The
following table sets forth the quarterly high and low intraday prices, as well as end-of-quarter closing prices on the relevant
exchange, of the Reference Stock for each quarter in the period from October 1, 2007 through February 22, 2013. We obtained the
data in these tables from the Bloomberg Professional
®
service, without independent verification by us. All historical
prices are denominated in US dollars and rounded to the nearest penny.
Historical prices of the Reference Stock should not
be taken as an indication of future performance of the Reference Stock.
Quarter Ending
|
Quarter High
|
Quarter Low
|
Quarter Close
|
|
Quarter Ending
|
Quarter High
|
Quarter Low
|
Quarter Close
|
December 31, 2007
|
$27.99
|
$24.32
|
$26.66
|
|
September 30, 2010
|
$22.25
|
$17.60
|
$19.23
|
March 31, 2008
|
$26.34
|
$18.05
|
$21.18
|
|
December 31, 2010
|
$22.07
|
$18.78
|
$21.03
|
June 30, 2008
|
$25.29
|
$20.50
|
$21.48
|
|
March 31, 2011
|
$22.20
|
$19.72
|
$20.17
|
September 30, 2008
|
$24.75
|
$17.27
|
$18.73
|
|
June 30, 2011
|
$23.96
|
$19.36
|
$22.16
|
December 31, 2008
|
$18.69
|
$12.07
|
$14.66
|
|
September 30, 2011
|
$23.39
|
$19.16
|
$21.33
|
March 31, 2009
|
$15.83
|
$12.05
|
$15.05
|
|
December 30, 2011
|
$25.78
|
$20.40
|
$24.25
|
June 30, 2009
|
$16.74
|
$14.62
|
$16.55
|
|
March 30, 2012
|
$28.44
|
$24.39
|
$28.11
|
September 30, 2009
|
$20.65
|
$15.78
|
$19.57
|
|
June 29, 2012
|
$29.27
|
$24.84
|
$26.65
|
December 31, 2009
|
$21.26
|
$18.31
|
$20.40
|
|
September 28, 2012
|
$26.90
|
$22.48
|
$22.68
|
March 31, 2010
|
$22.74
|
$18.96
|
$22.26
|
|
December 31, 2012
|
$23.17
|
$19.23
|
$20.63
|
June 30, 2010
|
$24.28
|
$19.40
|
$19.45
|
|
February 22, 2013*
|
$23.06
|
$20.10
|
$20.42
|
*
As of the date of this pricing supplement available information for the first calendar quarter of 2013 includes data for the period
from January 2, 2013 through February 22, 2013. Accordingly, the “Quarterly High,” “Quarterly Low” and
“Quarterly Close” data indicated are for this shortened period only and do not reflect complete data for first calendar
quarter of 2013.
The
graph below illustrates the daily performance of INTC’s common stock from February 22, 2008 through February 22, 2013 based
on information from the Bloomberg Professional
®
service. The market price of the Reference Stock on February 22,
2013 was $20.42.
Past performance of the Reference Stock is not indicative of the future performance of the Reference
Stock.
AT&T
inc. (T)
Description of AT&T Inc.
AT&T
Inc. has stated in its filings with the SEC that it is a communications holding company that provides local and long-distance phone
service, wireless and data communications, internet access and messaging, IP-based and satellite television, security services,
telecommunications equipment, and directory advertising and publishing. Information filed by T with the SEC under the Exchange
Act can be located by reference to its SEC file number: 001-08610 or its CIK Code:
0000732717
.
Historical Performance of AT&T
Inc.
The
following table sets forth the quarterly high and low intraday prices, as well as end-of-quarter closing prices on the relevant
exchange, of the Reference Stock for each quarter in the period from October 1, 2007 through February 22, 2013. We obtained the
data in these tables from the Bloomberg Professional
®
service. We have not undertaken any independent review of,
or made any due diligence inquiry with respect to, the information obtained from the Bloomberg Professional
®
service. All historical prices are denominated in US dollars and rounded to the nearest penny.
Historical prices of the
Reference Stock should not be taken as an indication of future performance of the Reference Stock.
Quarter Ending
|
Quarter High
|
Quarter Low
|
Quarter Close
|
|
Quarter Ending
|
Quarter High
|
Quarter Low
|
Quarter Close
|
December 31, 2007
|
$42.79
|
$36.25
|
$41.56
|
|
September 30, 2010
|
$29.15
|
$23.89
|
$28.60
|
March 31, 2008
|
$41.94
|
$32.95
|
$38.30
|
|
December 31, 2010
|
$29.55
|
$27.50
|
$29.38
|
June 30, 2008
|
$40.70
|
$32.64
|
$33.69
|
|
March 31, 2011
|
$30.96
|
$27.20
|
$30.60
|
September 30, 2008
|
$33.58
|
$27.51
|
$27.92
|
|
June 30, 2011
|
$31.93
|
$29.91
|
$31.41
|
December 31, 2008
|
$30.65
|
$20.90
|
$28.50
|
|
September 30, 2011
|
$31.77
|
$27.29
|
$28.52
|
March 31, 2009
|
$29.46
|
$21.62
|
$25.20
|
|
December 30, 2011
|
$30.30
|
$27.41
|
$30.24
|
June 30, 2009
|
$27.09
|
$23.38
|
$24.84
|
|
March 30, 2012
|
$31.97
|
$29.02
|
$31.23
|
September 30, 2009
|
$27.68
|
$23.19
|
$27.01
|
|
June 29, 2012
|
$36.00
|
$29.95
|
$35.66
|
December 31, 2009
|
$28.61
|
$25.00
|
$28.03
|
|
September 28, 2012
|
$38.58
|
$34.24
|
$37.70
|
March 31, 2010
|
$28.67
|
$24.61
|
$25.84
|
|
December 31, 2012
|
$38.43
|
$32.71
|
$33.71
|
June 30, 2010
|
$26.75
|
$23.78
|
$24.19
|
|
February 22, 2013*
|
$35.98
|
$32.76
|
$35.68
|
*
As of the date of this pricing supplement available information for the first calendar quarter of 2013 includes data for the period
from January 2, 2013 through February 22, 2013. Accordingly, the “Quarterly High,” “Quarterly Low” and
“Quarterly Close” data indicated are for this shortened period only and do not reflect complete data for first calendar
quarter of 2013.
The
graph below illustrates the daily performance of T’s common stock from February 22, 2008 through February 22, 2013 based
on information from the Bloomberg Professional
®
service. The market price of the Reference Stock on February 22,
2013 was $35.68.
Past performance of the Reference Stock is not indicative of the future performance of the Reference
Stock.
walgreen
co. (wag)
Description of Walgreen Co.
Walgreen
Co. has stated in its filings with the SEC that it operates retail drugstores that offer a wide variety of prescription and non-prescription
drugs as well as general goods. Information filed by WAG with the SEC under the Exchange Act can be located by reference to its
SEC file number: 001-00604 or its CIK Code: 0000104207.
Historical Performance of Walgreen
Co.
The
following table sets forth the quarterly high and low intraday prices, as well as end-of-quarter closing prices on the relevant
exchange, of the Reference Stock for each quarter in the period from October 1, 2007 through February 22, 2013. We obtained the
data in these tables from the Bloomberg Professional
®
service, without independent verification by us. All historical
prices are denominated in US dollars and rounded to the nearest penny.
Historical prices of the Reference Stock should not
be taken as an indication of future performance of the Reference Stock.
Quarter Ending
|
Quarter High
|
Quarter Low
|
Quarter Close
|
|
Quarter Ending
|
Quarter High
|
Quarter Low
|
Quarter Close
|
December 31, 2007
|
$47.24
|
$35.80
|
$38.08
|
|
September 30, 2010
|
$34.12
|
$26.27
|
$33.50
|
March 31, 2008
|
$38.89
|
$32.50
|
$38.09
|
|
December 31, 2010
|
$40.20
|
$33.05
|
$38.96
|
June 30, 2008
|
$39.00
|
$32.41
|
$32.51
|
|
March 31, 2011
|
$44.06
|
$38.45
|
$40.14
|
September 30, 2008
|
$37.85
|
$30.26
|
$30.96
|
|
June 30, 2011
|
$45.34
|
$40.31
|
$42.46
|
December 31, 2008
|
$30.96
|
$21.34
|
$24.67
|
|
September 30, 2011
|
$44.26
|
$32.00
|
$32.89
|
March 31, 2009
|
$28.38
|
$21.39
|
$25.96
|
|
December 30, 2011
|
$35.34
|
$30.35
|
$33.06
|
June 30, 2009
|
$32.20
|
$25.61
|
$29.40
|
|
March 30, 2012
|
$35.35
|
$32.32
|
$33.49
|
September 30, 2009
|
$38.44
|
$27.89
|
$37.47
|
|
June 29, 2012
|
$36.04
|
$28.53
|
$29.58
|
December 31, 2009
|
$40.69
|
$35.10
|
$36.72
|
|
September 28, 2012
|
$36.90
|
$29.35
|
$36.44
|
March 31, 2010
|
$37.60
|
$33.00
|
$37.09
|
|
December 31, 2012
|
$37.75
|
$31.88
|
$37.01
|
June 30, 2010
|
$37.95
|
$26.33
|
$26.70
|
|
February 22, 2013*
|
$42.00
|
$36.34
|
$41.81
|
*
As of the date of this pricing supplement available information for the first calendar quarter of 2013 includes data for the period
from January 2, 2013 through February 22, 2013. Accordingly, the “Quarterly High,” “Quarterly Low” and
“Quarterly Close” data indicated are for this shortened period only and do not reflect complete data for first calendar
quarter of 2013.
The
graph below illustrates the daily performance of WAG’s common stock from February 22, 2008 through February 22, 2013 based
on information from the Bloomberg Professional
®
service. The market price of the Reference Stock on February 22,
2013 was $41.81.
Past performance of the Reference Stock is not indicative of the future performance of the Reference
Stock.
Illustrative
ExampleS
The following examples are provided for illustrative
purposes only and are hypothetical.
These examples are representative of only a few possible scenarios concerning increases
or decreases in the prices of the Reference Stocks relative to their Initial Prices and how those increases and decreases affect
the Coupons payable on the Notes.
We cannot predict the Official Closing Prices of the Reference Stocks on the Coupon Valuation
Dates. The assumptions we have made in connection with the illustrations set forth below may not reflect actual events, and you
should not take these examples as an indication or assurance of the expected performance of the Reference Stocks or the return
on the Notes.
The total payment you receive over the term of the Notes may be less than the amount that you would have received
from a conventional debt security with the same stated maturity, including those issued by HSBC.
The examples below illustrate the Coupon Payments
on a $1,000 investment in the Notes for a hypothetical range of performance for the Reference Stocks. The following results are
based solely on the assumptions outlined below. The potential returns described here show potential valuations for different Coupon
Valuation Dates during the term of the Notes. You should consider carefully whether the Notes are suitable to your investment goals.
The numbers appearing below have been rounded for ease of analysis.
}
|
Principal Amount:
|
$1,000
|
|
|
|
}
|
Hypothetical Minimum
Coupon Rate:
|
1.00% (The actual Minimum Coupon Rates corresponding to each offering of the Notes are specified on page PS-2)
|
|
|
|
}
|
Hypothetical
Performance-Based
Coupon Rate:
|
6.00% (The actual Performance-Based Coupon Rates corresponding to each offering of the Notes are specified on page PS-2)
|
The Initial Prices were determined on the
Pricing Date.
Example 1: The Reference Stock Return for each
Reference Stock is greater than or equal to zero on the Coupon Valuation Date
Reference Stock
|
Hypothetical Reference Stock Return
|
BMY
|
12.00%
|
COP
|
2.50%
|
INTC
|
5.00%
|
T
|
1.00%
|
WAG
|
2.00%
|
Minimum Coupon Rate =
|
1.00%
|
|
Performance-Based Coupon Rate =
|
6.00%
|
|
Coupon =
|
$70.00
|
|
|
|
|
|
Explanation for Example 1
As illustrated above, the hypothetical Reference
Stock Return for each of the 5 Reference Stocks is greater than or equal to zero. Therefore, even though the hypothetical Reference
Stock Return for one of the Reference Stocks is greater than the Performance-Based Coupon Rate plus the Minimum Coupon Rate, the
payment will be limited to the hypothetical Performance-Based Coupon Rate of 6.00% plus the hypothetical Minimum Coupon Rate of
1.00%. Therefore, you receive a Coupon of $70.00 on the applicable Coupon Payment Date.
Example 2: The Reference Stock Return for 1 of
the 5 Reference Stocks is less than zero on the Coupon Valuation Date
Reference Stock
|
Hypothetical Reference Stock Return
|
BMY
|
12.00%
|
COP
|
5.00%
|
INTC
|
5.00%
|
T
|
0.00%
|
WAG
|
-4.00%
|
Minimum Coupon Rate =
|
1.00%
|
|
Performance-Based Coupon Rate =
|
6.00%
|
|
Coupon =
|
$10.00
|
|
|
|
|
|
Explanation for Example 2
As illustrated above, the hypothetical Reference
Stock Return of 4 of the 5 of the Reference Stocks (BMY, COP, INTC and T) is greater than or equal to zero. However, the Reference
Stock Return of 1 of the 5 Reference Stocks (WAG) is less than zero. Because the Reference Stock Return is less than zero for one
of the Reference Stocks, the Coupon will equal the Minimum Coupon Rate. Therefore, you receive a Coupon of $10.00 on the applicable
Coupon Payment Date.
Events of Default
and Acceleration
With respect to each offering of Notes, if such Notes
have become immediately due and payable following an event of default (as defined in the accompanying prospectus) with respect
to such Notes, the calculation agent will determine (i) the accelerated Payment at Maturity due and payable in the same general
manner as described in Payment at Maturity in this pricing supplement and (ii) any accrued but unpaid interest payable. In
such a case, the business day immediately preceding the date of acceleration will be used as the Coupon Valuation Date for purposes
of determining the Coupon payable on the Notes on the accelerated Maturity Date. The accelerated Maturity Date will be the
third business day following the accelerated final Coupon Valuation Date.
If such Notes have become immediately due and payable
following an event of default, you will not be entitled to any additional payments with respect to such Notes. For more information,
see “Description of Debt Securities — Senior Debt Securities — Events of Default” in the prospectus.
Supplemental Plan
of Distribution (Conflicts of Interest)
We have appointed HSBC Securities (USA) Inc., an
affiliate of HSBC, as the agent for the sales of the Notes. Pursuant to the terms of a distribution agreement, HSBC Securities
(USA) Inc. will purchase the Notes from HSBC at the price to public less the underwriting discount set forth on the cover page
of this pricing supplement, for distribution to other registered broker-dealers or will offer the Notes directly to investors.
HSBC Securities (USA) Inc. will offer the Notes at the price to public set forth on the cover page of this pricing supplement.
HSBC USA Inc. or one of our affiliates may pay varying underwriting discounts of up to 4.25% and referral fees of up to 1.75% per
$1,000 Principal Amount of Notes in connection with the distribution of the Notes to other registered broker-dealers. In no case
will the sum of the underwriting discounts and referral fees exceed 4.75% per $1,000 Principal Amount.
An affiliate of HSBC has paid or may pay in the future
an amount to broker-dealers in connection with the costs of the continuing implementation of systems to support the Notes.
In addition, HSBC Securities (USA) Inc. or another
of its affiliates or agents may use this pricing supplement in market-making transactions after the initial sale of the Notes,
but is under no obligation to make a market in the Notes and may discontinue any market-making activities at any time without notice.
See “Supplemental Plan of Distribution (Conflicts
of Interest)” on page S-49 in the prospectus supplement.
U.S. Federal Income
Tax Considerations
You should carefully consider the matters set forth
in “U.S. Federal Income Tax Considerations” in the accompanying prospectus supplement. The following discussion summarizes
the U.S. federal income tax consequences of the purchase, beneficial ownership, and disposition of the Notes. This summary supplements
the section “U.S. Federal Income Tax Considerations” in the accompanying prospectus supplement and supersedes it to
the extent inconsistent therewith.
There are no statutory provisions, regulations, published
rulings or judicial decisions addressing the characterization for U.S. federal income tax purposes of securities with terms that
are substantially the same as those of the Notes. We intend to treat the Notes as variable rate debt instruments for U.S. federal
income tax purposes. Pursuant to the terms of the Notes, you agree to treat the Notes as variable rate debt instruments for all
U.S. federal income tax purposes and, based on certain factual representations received from us, in the opinion of Morrison &
Foerster LLP, our special U.S. tax counsel, it is reasonable to treat the Notes as variable rate debt instruments. Assuming the
Notes are treated as variable rate debt instruments, Coupons paid on the Notes generally should be taxable to you as ordinary interest
income at the time they accrue or are received in accordance with the your regular method of accounting for U.S. federal income
tax purposes. You should review the discussion set forth in “U.S. Federal Income Tax Considerations — U.S. Federal
Income Tax Treatment of the Notes as Indebtedness for U.S. Federal Income Tax Purposes — Variable Rate Debt Instruments”
in the accompanying prospectus supplement. In general, gain or loss realized on the sale, exchange or other disposition of the
Notes will be capital gain or loss.
We will not attempt to ascertain whether any Reference
Stock Issuer would be treated as a passive foreign investment company (“PFIC”) or a United States real property holding
corporation (“USRPHC”), both as defined for U.S. federal income tax purposes. If a Reference Stock Issuer were so treated,
certain adverse U.S. federal income tax consequences might apply. You should refer to information filed with the SEC by the Reference
Stock Issuers and consult your tax advisor regarding the possible consequences to you if a Reference Stock Issuer is or becomes
a PFIC or a USRPHC.
Withholding and reporting requirements under the
legislation enacted on March 18, 2010 (as discussed beginning on page S-48 of the prospectus supplement) will generally apply to
payments made after December 31, 2013. However, this withholding tax will not be imposed on payments pursuant to obligations outstanding
on January 1, 2014. Additionally, withholding due to any payment being treated as a “dividend equivalent” (as discussed
beginning on page S-47 of the prospectus supplement) will begin no earlier than January 1, 2014. Holders are urged to consult with
their own tax advisors regarding the possible implications of this recently enacted legislation on their investment in the Notes.
Because there are no statutory provisions, regulations,
published rulings or judicial decisions addressing the characterization for U.S. federal income tax purposes of securities with
terms that are substantially the same as those of the Notes, other characterizations and treatments are possible. As a result,
the timing and character of income in respect of the Notes might differ from the treatment described above. For example, the Notes
may be treated as “contingent payment debt instruments” for U.S. federal income tax purposes, subject to taxation under
the “noncontingent bond method,” as described in the discussion under “U.S. Federal Income Tax Considerations
— U.S. Federal Income Tax Treatment of the Notes as Indebtedness for U.S. Federal Income Tax Purposes — Contingent
Payment Debt Instruments” in the accompanying prospectus supplement. You should carefully consider the discussion of all
potential tax consequences as set forth in “U.S. Federal Income Tax Considerations” in the accompanying prospectus
supplement.
PROSPECTIVE PURCHASERS OF THE NOTES SHOULD CONSULT
THEIR TAX ADVISORS AS TO THE FEDERAL, STATE, LOCAL, AND OTHER TAX CONSEQUENCES TO THEM OF THE PURCHASE, OWNERSHIP AND DISPOSITION
OF THE NOTES.
validity of the
notes
In the opinion of Morrison
& Foerster LLP, as counsel to the Issuer, when the Notes offered by this pricing supplement have been executed and delivered
by the Issuer and authenticated by the trustee pursuant to the Senior Indenture referred to in the prospectus supplement dated
March 22, 2012, and issued and paid for as contemplated herein, such Notes will be valid, binding and enforceable obligations of
the Issuer, entitled to the benefits of the Senior Indenture, subject to applicable bankruptcy, insolvency and similar laws affecting
creditors’ rights generally, concepts of reasonableness and equitable principles of general applicability (including, without
limitation, concepts of good faith, fair dealing and the lack of bad faith). This opinion is given as of the date hereof and is
limited to the laws of the State of New York, the Maryland General Corporation Law (including the statutory provisions, all applicable
provisions of the Maryland Constitution and the reported judicial decisions interpreting the foregoing) and the federal laws of
the United States of America. This opinion is subject to customary assumptions about the trustee’s authorization, execution
and delivery of the Senior Indenture and the genuineness of signatures and to such counsel’s reliance on the Issuer and other
sources as to certain factual matters, all as stated in the legal opinion dated July 27, 2012, which has been filed as Exhibit
5.1 to the Issuer’s Current Report on Form 8-K dated July 27, 2012.
TABLE OF CONTENTS
|
|
|
You should only rely on the
information contained in this pricing supplement, the accompanying Stock-Linked Underlying Supplement, prospectus supplement and
prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained
in this pricing supplement, the accompanying Stock-Linked Underlying Supplement, prospectus supplement and prospectus. If anyone
provides you with different or inconsistent information, you should not rely on it. This pricing supplement, the accompanying Stock-Linked
Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these Notes, and these documents are not soliciting
an offer to buy these Notes, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances,
assume that the information in this pricing supplement, the accompanying Stock-Linked Underlying Supplement, prospectus supplement
and prospectus is correct on any date after their respective dates.
HSBC USA Inc.
$576,000
7 Year Income Plus Notes with a 1.00% Minimum Annual Coupon
$1,395,000
7 Year Income Plus Notes with a 0.50% Minimum Annual Coupon
February
22, 2013
PRICING
SUPPLEMENT
|
|
|
|
Pricing Supplement
|
|
|
General
|
PS-4
|
|
Payment at Maturity
|
PS-4
|
|
Investor Suitability
|
PS-5
|
|
Risk Factors
|
PS-5
|
|
Description of the Reference Stocks.
|
PS-7
|
|
Illustrative Examples
|
PS-12
|
|
Events of Default and Acceleration
|
PS-14
|
|
Supplemental Plan of Distribution (Conflicts of Interest)
|
PS-14
|
|
U.S. Federal Income Tax Considerations
|
PS-15
|
|
Validity of the Notes
|
PS-15
|
|
|
|
|
Stock-Linked Underlying Supplement
|
|
|
Risk Factors
|
S-1
|
|
Additional Note Terms
|
S-5
|
|
Information Regarding the Reference Stocks and the Reference Stock Issuers
|
S-11
|
|
|
|
|
Prospectus Supplement
|
|
|
Risk Factors
|
S-3
|
|
Risks Relating to Our Business
|
S-3
|
|
Risks Relating to All Note Issuances
|
S-3
|
|
Pricing Supplement
|
S-7
|
|
Description of Notes
|
S-8
|
|
Use of Proceeds and Hedging
|
S-30
|
|
Certain ERISA Considerations
|
S-30
|
|
U.S. Federal Income Tax Considerations
|
S-32
|
|
Supplemental Plan of Distribution (Conflicts of Interest)
|
S-49
|
|
|
|
|
Prospectus
|
|
|
About this Prospectus
|
1
|
|
Risk Factors
|
1
|
|
Where You Can Find More Information
|
1
|
|
Special Note Regarding Forward-Looking Statements
|
2
|
|
HSBC USA Inc.
|
3
|
|
Use of Proceeds
|
3
|
|
Description of Debt Securities
|
3
|
|
Description of Preferred Stock
|
15
|
|
Description of Warrants
|
21
|
|
Description of Purchase Contracts
|
25
|
|
Description of Units
|
28
|
|
Book-Entry Procedures
|
30
|
|
Limitations on Issuances in Bearer Form
|
35
|
|
U.S. Federal Income Tax Considerations Relating to Debt Securities
|
35
|
|
Plan of Distribution (Conflicts of Interest)
|
51
|
|
Notice to Canadian Investors
|
53
|
|
Notice to EEA Investors
|
58
|
|
Certain ERISA Matters
|
59
|
|
Legal Opinions
|
60
|
|
Experts
|
60
|
|
Donnelley (R.R.) & Sons Co. (NYSE:RRD.WI)
Historical Stock Chart
From Sep 2024 to Oct 2024
Donnelley (R.R.) & Sons Co. (NYSE:RRD.WI)
Historical Stock Chart
From Oct 2023 to Oct 2024